Σπουδές

Σεπτέμβριος 2020
Απόκτηση τίτλου ειδικότητας Ρευματολογίας

Μάρτιος 2014
Διδακτορική Διατριβή με τίτλο «Κλινική εξέλιξη στο σύνδρομο Αντιφωσφολιπιδίων»

2001-2007
Πτυχίο (M.D.) Ιατρικής , Ιατρική Σχολή Εθνικού Καποδιστριακού Πανεπιστημίου Αθηνών (Ε.Κ.Π.Α.)

Προϋπηρεσία

02/2021- 07/2021
Επικουρική Ιατρός στη Ρευματολογική Κλινική του ΓΝΑ « Ο Ευαγγελισμός»

07/2016 – 09/2020
Ειδικότητα Ρευματολογίας ΓΝΑ « Ο Ευαγγελισμός»

11/2013 – 07/2016
Επιστημονική συνεργάτης Κλινικής και Εργαστηρίου Παθολογικής Φυσιολογίας ΓΝΑ “Λαϊκό” – Υπεύθυνη τμήματος κλινικών μελετών

11/2011 – 11/2013
Άσκηση Παθολογίας ΓΝΑ “Η Ελπίς”

Συγγραφικό έργο

Disease characteristics, co-morbidities and treatment response in a contemporary axial spondyloarthritis cohort: Analysis of 717 patients from the Greek AxSpA registry
Papagoras C, Fragoulis GE, Fytanidis N, Krikelis M, Mole E, Gazi S, Skepastianos V, Kougkas N, Dimitroulas T, Koletsos N, Kaltsonoudis E, Voulgari PV, Karamanakos A, Pappa M, Tektonidou MG, Sfikakis PP, Klavdianou K, Kalavri E, Kottas K, Katsifis G, Konsta M, Grika EP, Sfontouris C, Mavrea E, Koutsianas C, Kataxaki E, Sampatakaki E, Zoupidou K, Katsimpri P, Iliopoulos A, Iliopoulos G, Daoussis D, Bournazos I, Karokis D, Patrikos D, Vassilopoulos D.
Semin Arthritis Rheum. 2025 Apr;71:152645

Identification and characteristics of patients with potential difficult-to-treat psoriatic arthritis: exploratory analyses of the Greek PsA registry
Vassilakis KD, Papagoras C, Fytanidis N, Gazi S, Mole E, Krikelis M, Voulgari PV, Kaltsonoudis E, Koletsos N, Boumpas D, Katsimpri P, Katsifis-Nezis D, Dimitroulas T, Kougkas N, Boutel M, Sfikakis PP, Tektonidou MG, Gialouri C, Bogdanos D, Simopoulou T, Koutsianas C, Mavrea E, Katsifis G, Kottas K, Konsta M, Tziafalia M, Kataxaki E, Kalavri E, Klavdianou K, Grika EP, Sfontouris C, Daoussis D, Iliopoulos G, Bournazos I, Karokis D, Georganas K, Patrikos D, Vassilopoulos D, Fragoulis GE.
Rheumatology (Oxford). 2024 Sep 1;63(9):2427-2432

Disease Profile and Achievement of Therapeutic Goals in a Modern, Nationwide Cohort of 923 Patients with Psoriatic Arthritis
Fragoulis GE, Papagoras C, Gazi S, Mole E, Krikelis M, Voulgari PV, Kaltsonoudis E, Koletsos N, Katsimpri P, Boumpas D, Katsifis D, Kougkas N, Dimitroulas T, Sfikakis PP, Tektonidou MG, Gialouri C, Bogdanos DP, Simopoulou T, Koutsianas C, Mavrea E, Katsifis G, Kottas K, Konsta M, Tziafalia M, Kataxaki E, Kalavri E, Klavdianou K, Grika EP, Sfontouris C, Daoussis D, Iliopoulos G, Bournazos I, Karokis D, Georganas K, Patrikos D, Vassilopoulos D.
Mediterr J Rheumatol. 2023 Dec 30;34(4):418-426

Patterns and factors associated with pneumococcal vaccination in a prospective cohort of 1,697 patients with rheumatoid arthritis
Thomas K, Lazarini A, Kaltsonoudis E, Voulgari PV, Drosos AA, Repa A, Sali AMI, Sidiropoulos P, Tsatsani P, Gazi S, Fragkiadaki K, Tektonidou MG, Sfikakis PP, Katsimbri P, Boumpas D, Argyriou E, Boki KA, Karagianni K, Katsiari C, Evangelatos G, Iliopoulos A, Grika EP, Vlachoyiannopoulos PG, Dimitroulas T, Garyfallos A, Melissaropoulos K, Georgiou P, Georganas C, Vounotrypidis P, Ntelis K, Areti M, Kitas GD, Vassilopoulos D.
Front Med (Lausanne). 2023 Jan 9;9:1039464

Outcome of refractory to conventional and/or biologic treatment adult Still’s disease following canakinumab treatment: Countrywide data in 50 patients
K.Laskari, ,M.G.Tektonidou, C.Katsiari, P.Athanassiou, D.Dimopoulou, C.Gerodimos, C.Salamaliki, C.Papagoras, L.Settas, D.Vassilopoulos, P.V.Voulgari, M.Zakalka, A.Georgiadis, G.Gkoni, D.Daoussis, T.Dimitroulas, C.Iliou, I.Kallitsakis, E.P.Grika, C.Mavragani, D.Pikazis, J.Raftakis, T.Sarikoudis, N.Kougkas, D.Soukera, E.Theodorou, P.Tsatsani, E.Tsiakou, P.Vlachoyiannopoulos, G.Vosvotekas, P.P.Sfikakis
Seminars In Arthritis and Rheumatism Volume 51, Issue 1, Feb 2021, Pages 137-143

Incidence, risk factors and validation of the RABBIT score for serious infections in a cohort of 1557 patients with rheumatoid arthritis
Konstantinos Thomas, Argyro Lazarini, Evripidis Kaltsonoudis, Paraskevi V Voulgari, Alexandros A Drosos, Argyro Repa, Ainour Molla Ismail Sali, Prodromos Sidiropoulos, Panagiota Tsatsani, Sousana Gazi, Argyriou Evangelia, Kyriaki A Boki, Pelagia Katsimbri, Dimitrios Boumpas, Kalliopi Fragkiadaki, Maria G Tektonidou, Petros P Sfikakis, Konstantina Karagianni, Lazaros I Sakkas, Eleftheria P Grika, Panagiotis G Vlachoyiannopoulos, Gerasimos Evangelatos, Alexios Iliopoulos, Theodoros Dimitroulas, Alexandros Garyfallos, Konstantinos Melissaropoulos, Panagiotis Georgiou, Maria Areti, Constantinos Georganas, Periklis Vounotrypidis, Georgios Georgiopoulos, George D Kitas, Dimitrios Vassilopoulos
Rheumatology (Oxford). 2021 May 14;60(5):2223-2230

Treatment patterns and achievement of the treat-to-target goals in a real-life rheumatoid arthritis patient cohort: data from 1317 patients
Konstantinos Thomas, Argiro Lazarini, Evripidis Kaltsonoudis, Alexandros Drosos, Ioannis Papalopoulos, Prodromos Sidiropoulos, Panagiota Tsatsani, Sousana Gazi, Lina Pantazi, Kyriaki A Boki, Pelagia Katsimbri, Dimitrios Boumpas, Kalliopi Fragkiadaki, Maria Tektonidou, Petros P Sfikakis, Konstantina Karagianni, Lazaros I Sakkas, Eleftheria P Grika, Panagiotis G Vlachoyiannopoulos, Gerasimos Evangelatos, Alexios Iliopoulos, Theodoros Dimitroulas, Alexandros Garyfallos, Konstantinos Melissaropoulos, Panagiotis Georgiou, Maria Areti, Constantinos Georganas, Periklis Vounotrypidis, George D Kitas, Dimitrios Vassilopoulos
Ther Adv Musculoskelet Dis.2020 Sep 28;12:1759720X20937132

Multicenter Cross-sectional Study of Patients with Rheumatoid Arthritis in Greece: Results from a cohort of 2.491 patients
Konstantinos Thomas, Argiro Lazarini, Evripidis Kaltsonoudis, Alexandros Drosos, Ioannis Papalopoulos, Prodromos Sidiropoulos, Pelagia Katsimbri, Dimitrios Boumpas, Panagiota Tsatsani, Sousana Gazi, Kalliopi Fragkiadaki, Maria Tektonidou, Petros P. Sfikakis, Lina Pantazi, Kyriaki A. Boki, Eleftheria P. Grika, Panagiotis G. Vlachoyiannopoulos, Konstantina Karagianni, Lazaros I. Sakkas, Theodoros Dimitroulas, Alexandros Garyfallos, Dimitrios Kassimos, Gerasimos Evangelatos, Alexios Iliopoulos, Maria Areti, Constantinos Georganas, Konstantinos Melissaropoulos, Panagiotis Georgiou, Periklis Vounotrypidis, Konstantinos Ntelis, Clio P. Mavragani, Ilias Bournazos, Gikas Katsifis, Christos Mavrommatis, George D. Kitas, Dimitrios Vassilopoulos
Mediterr J Rheumatol 2018;29(1):27-37

Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome
Patsouras MD, Sikara MP, Grika EP, Moutsopoulos HM, Tzioufas AG, Vlachoyiannopoulos PG
J Autoimmun. 2015 Dec;65:30-7

Morbidity, mortality, and organ damage in patients with antiphospholipid syndrome
Grika EP, Ziakas PD, Zintzaras E, Moutsopoulos HM, Vlachoyiannopoulos PG
J Rheumatol. 2012 Mar;39(3):516-23

Chapter: Pathogenic Mechanisms of Thrombosis in Antiphospholipid Syndrome (APS)
by Marina P. Sikara, Eleftheria P. Grika and Panayiotis G. Vlachoyiannopoulos
“Thrombophilia” ISBN 978-953-307-872-4, InTech, November 11, 2011

Συμμετοχές σε συνέδρια

I. Προφορικές Ανακοινώσεις

Thrombospondin-1 is elevated in the plasma of patients with antiphospholipid syndrome: implications in the pathogenesis of antiphispholipid syndrome
Markos D. Patsouras, Eleftheria P. Grika, Athanasios G Tzioufas, Panayiotis G. Vlachoyiannopoulos
10th European Lupus Meeting, 5-8 October 2016, Venice, Italy

Thrombospondin-1 is elevated in the plasma of patients with antiphospholipid syndrome: implications in the pathogenesis of antiphispholipid syndrome
Markos D. Patsouras, Eleftheria P. Grika, Athanasios G Tzioufas, Panayiotis G. Vlachoyiannopoulos
European Congress on Thrombosis and Haemostasis, 28 – 30 September 2016, The Hague, The Netherlands

Thrombospondin-1 is elevated in the plasma of patients with antiphospholipid syndrome and is correlated with free active TGF-B1 levels, IL-1B and IL-17A
Markos D. Patsouras, Eleftheria P. Grika, Athanasios G Tzioufas, Panayiotis G. Vlachoyiannopoulos
6th Turkish Greek Rheumatology Days, 24-27 March 2016, Κωνσταντινούπολη, Τουρκία

End-Stage Organ Damage and Mortality in Patients with Antiphospholipid Syndrome (APS): Prognostic Models for Serious Clinical Outcomes
Eleftheria P. Grika, Elias Zintzaras, Haralampos M. Moutsopoulos, Panayiotis G. Vlachoyiannopoulos
73rd Annual Scientific Meeting of the American College of Rheumatology, 16-21 October 2009, Philadelphia, Pennsylvania

Μείζονες κλινικές εκφράσεις του Συνδρόμου Αντιφωσφολιπιδίων (ΣΑΦ)- Προβλεπτική αξία των αρχικών κλινικών συμβαμάτων
Ε.Π. Γρίκα, Η. Ζιντζαράς, Χ.Μ. Μουτσόπουλος, Π.Γ. Βλαχογιαννόπουλος
20ο Πανελλήνιο Συνέδριο Ρευματολογίας, 26-29 Νοεμβρίου 2008, Αθήνα, Ελλάδα

IΙ. Αναρτημένες Ανακοινώσεις

A Non-Interventional Prospective Observational Study of Treatment with Etanercept Biosimilar (SB4) in Rheumatoid Arthritis in Real Life Clinical Practice; Interim Analysis of the ‘BENEFICIAL’ Study
Panagiotis Athanassiou, Andreas Bounas, Dimitrios Boumpas, Prodromos Sidiropoulos, Christina Tsalapaki, Alexandros Garyfallos, Eleftheria Grika, Paraskevi V. Voulgari, Angeliki Kekki, Zafeirios Anagnostopoulos, Rania Gourgioti, Georgios Karachalios, Nikos Antonakopoulos
Annual Scientific Meeting of the American College of Rheumatology, 3-9 November 2021, Virtual Congress

Low rates of retention of biologic dmard monotherapy in patients with rheumatoid arthritis in real life settings
Argyro Lazarini, Konstantinos Thomas, Evripidis Kaltsonoudis, Paraskevi V Voulgari, Alexandros A Drosos, Argyro Repa, Ainour Molla Ismail Sali, Prodromos Sidiropoulos, Panagiota Tsatsani, Sousana Gazi, Argyriou Evangelia, Kyriaki A Boki, Pelagia Katsimbri, Dimitrios Boumpas, Kalliopi Fragkiadaki, Maria G Tektonidou, Petros P Sfikakis, Konstantina Karagianni, Lazaros I Sakkas, Eleftheria P Grika, Panagiotis G Vlachoyiannopoulos, Gerasimos Evangelatos, Alexios Iliopoulos, Theodoros Dimitroulas, Alexandros Garyfallos, Konstantinos Melissaropoulos, Panagiotis Georgiou, Maria Areti, Constantinos Georganas, Periklis Vounotrypidis, Georgios Georgiopoulos, George D Kitas, Dimitrios Vassilopoulos
Annual European Congress of Rheumatology 13-16 June 2018, Amsterdam, The Netherlands

Dyslipidemia is undertreated in patients with rheumatoid arthritis: Results from a large cohort of RA patients in daily clinical practice.
K. Thomas, A Lazarini, E Kaltsonoudis, A Drosos, P Katsimbri, D Boumpas, P Tsatsani, S Gazi, E Grika, P Vlachogiannopoulos, P P Sfikakis, K Karagianni, L Sakkas, L Pantazi, K Boki, T Dimitroulas, G Evangelatos, A Iliopoulos, C Georganas, P Vounotrypidis, M Areti, P Georgiou, K Mavragani, I Bournazos, G Ktasifis, G Kitas, D Vassilopoulos
Annual European Congress of Rheumatology 8-11 June 2016, London, United Kingdom

Morbidity and mortality in patients with antiphospholipid syndrome: Prognostic factors for serious clinical outcomes
Grika E.P., Bournia V.K., Zintzaras E., Moutsopoulos H.M., Vlachoyiannopoulos P.G.
8th European Lupus Meeting, 6-9 April 2011, Porto, Portugal

Detection of ischemic lesions in patients with antiphospholipid syndrome (APS) using positron emission tomography (18FDG-PET/CT) and magnetiv resonance imaging (MRI)
E. P. Grika, R. Manavaki, S. Chatziioannou, M. Kallergi, S. Lachanis, H. M. Moutsopoulos, P. G. Vlachoyiannopoulos
Annual European Congress of Rheumatology, 16-19 June 2010, Rome, Italy